Hualan Biological Bacterin Inc.
SZSE:301207.SZ
27.9 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 623.035 | 640.98 | 600.042 | 131.565 | 412.389 | 278.699 | 143.015 | 26.587 |
| Short Term Investments
| 1,458.145 | 1,971.982 | 1,419.299 | 825.824 | 452.857 | 221.902 | 210 | 280 |
| Cash and Short Term Investments
| 2,081.18 | 2,612.962 | 2,019.341 | 957.389 | 865.246 | 500.601 | 143.015 | 26.587 |
| Net Receivables
| 1,437.961 | 1,991.812 | 1,796.443 | 1,438.966 | 1,529.807 | 692.059 | 542.129 | 174.372 |
| Inventory
| 208.839 | 173.471 | 167.157 | 107.408 | 45.27 | 55.794 | 78.411 | 59.615 |
| Other Current Assets
| 1,248.54 | 476.752 | 209.386 | 25.464 | 500.755 | 245.293 | 14.912 | 288.958 |
| Total Current Assets
| 4,976.52 | 5,226.815 | 4,192.738 | 2,529.227 | 2,465.36 | 1,261.769 | 988.466 | 549.532 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 1,069.632 | 1,174.786 | 1,286.278 | 1,349.737 | 808.726 | 346.937 | 250.686 | 195.1 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 48.674 | 46.395 | 44.943 | 43.959 | 41.666 | 36.782 | 32.899 | 25.296 |
| Goodwill and Intangible Assets
| 48.674 | 46.395 | 44.943 | 43.959 | 41.666 | 36.782 | 32.899 | 25.296 |
| Long Term Investments
| 0 | 1,296.105 | 5.177 | 12.396 | 2.242 | 2.673 | 2.35 | 1.723 |
| Tax Assets
| 212.727 | 217.969 | 208.56 | 182.899 | 170.41 | 87.13 | 67.094 | 40.776 |
| Other Non-Current Assets
| 1,215.703 | 33.247 | 1,337.82 | 405.228 | 159.607 | 58.813 | 26.586 | 33.259 |
| Total Non-Current Assets
| 2,546.736 | 2,768.503 | 2,882.779 | 1,994.22 | 1,182.651 | 532.335 | 379.616 | 296.153 |
| Total Assets
| 7,523.256 | 7,995.318 | 7,075.517 | 4,523.447 | 3,648.011 | 1,794.104 | 1,368.082 | 845.685 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 81.776 | 116.76 | 125.67 | 185.502 | 105.461 | 15.34 | 20.088 | 17.263 |
| Short Term Debt
| 300.183 | 300.183 | 300.183 | 500.435 | 200 | 0 | 0 | 0 |
| Tax Payables
| 2.301 | 50.812 | 12.895 | 25.684 | 161.135 | 39.164 | 59.88 | 1.701 |
| Deferred Revenue
| 0 | 0 | 1,110.941 | 985.146 | 1,149.088 | 3.401 | 3.451 | 0 |
| Other Current Liabilities
| 1,079.863 | 1,217.828 | 1,095.443 | 958.999 | 987.099 | 476.675 | 401.187 | 209.941 |
| Total Current Liabilities
| 1,464.123 | 1,685.583 | 1,536.874 | 1,672.161 | 1,454.599 | 531.179 | 481.155 | 228.906 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 0 | 0 | 0 | 0.806 | 1.838 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 27.188 | 31.422 | 35.656 | 39.891 | 6 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 18.801 | 15.222 | 6.411 | 2.497 | 0.279 | 0.7 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | -1.838 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 45.989 | 46.644 | 42.067 | 43.194 | 6.279 | 0.7 | 0 | 0 |
| Total Liabilities
| 1,510.111 | 1,732.226 | 1,578.941 | 1,715.354 | 1,460.878 | 531.879 | 481.155 | 228.906 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 601.028 | 600.015 | 400.01 | 360 | 360 | 100 | 100 | 100 |
| Retained Earnings
| 2,292.285 | 2,461.743 | 1,807.93 | 1,411.36 | 852.631 | 1,112.225 | 736.927 | 469.167 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 204.653 | 156.942 | 189.423 | 50 | 50 | 0 |
| Other Total Stockholders Equity
| 3,119.832 | 3,201.333 | 3,288.637 | 1,036.733 | 974.515 | 0 | 0 | 47.612 |
| Total Shareholders Equity
| 6,013.145 | 6,263.092 | 5,496.576 | 2,808.092 | 2,187.134 | 1,262.225 | 886.927 | 616.779 |
| Total Equity
| 6,013.145 | 6,263.092 | 5,496.576 | 2,808.092 | 2,187.134 | 1,262.225 | 886.927 | 616.779 |
| Total Liabilities & Shareholders Equity
| 7,523.256 | 7,995.318 | 7,075.517 | 4,523.447 | 3,648.011 | 1,794.104 | 1,368.082 | 845.685 |